Bicycle Therapeutics Q3 Revenue Climbs 190.4% to $34.06 Million

John Kim

1 min read

Add as a preferred source on Google

Bicycle Therapeutics Q3 Revenue Climbs 190.4% to $34.06 Million

GAAP EPS was a loss of $0.15, $0.33 above estimates. Revenue exceeded estimates by $21.86 million.

By John Kim

Published Oct 29, 2026, 10:02 AM EDT

A clear vial stands beside a rising row of metal blocks / TokenPost.ai

Bicycle Therapeutics plc (NASDAQ: BCYC) posted third-quarter revenue of $34.06 million, up 190.4% year over year, while its GAAP loss per share was narrower than analysts expected.

Revenue exceeded estimates by $21.86 million. GAAP earnings per share were a loss of $0.15, beating estimates by $0.33.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.